DexCom (DXCM) Misses Q4 EPS by 7c ; Offers Guidance

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.45, $0.07 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.1 billion.

GUIDANCE:

DexCom sees FY2025 revenue of ~$4.6 billion, versus the consensus of $4.61 billion.

Non-GAAP Gross Profit Margin of approximately 64% - 65%
Non-GAAP Operating Margin of approximately 21%
Adjusted EBITDA Margin of approximately 30%

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings